title: Severe hypocalcemia following denosumab injection in patient with chronic kidney disease.
authors.affiliation: Servicio de Endocrinología, Hospital Universitario Marqués de Valdecilla, Santander (Cantabria), España.
authors.forename: Pilar
authors.initials: P
authors.lastname: Monge Rafael
authors.affiliation: Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander (Cantabria), España.
authors.forename: Manuel
authors.initials: M
authors.lastname: Arias
authors.affiliation: Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander (Cantabria), España. Electronic address: nefffg@humv.es.
authors.forename: Gema
authors.initials: G
authors.lastname: Fernández-Fresnedo
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D002117:Calcitriol / Q000627:therapeutic use; D002119:Calcium Carbonate / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use; D002762:Cholecalciferol / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy / Q000209:etiology; D000069448:Denosumab / Q000008:administration & dosage / Q000009:adverse effects*; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000628:therapy; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000209:etiology; D010024:Osteoporosis / Q000139:chemically induced / Q000188:drug therapy; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000209:etiology; D000069603:Sevelamer / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D002614:Chelating Agents; D002762:Cholecalciferol; D000069448:Denosumab; D000069603:Sevelamer; D002117:Calcitriol; D002119:Calcium Carbonate